JD Health (06618) announced that on January 1, 2026, the company granted 536,500 award shares, involving 536,500 new shares, to the grantees under the post-IPO share award scheme. This represents approximately 0.02% of the total number of issued shares as of the grant date.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments